Role of miR-21 and its signaling pathways in renal diseases

Journal of Receptors and Signal Transduction

Volumn 34, Issue 5, 2014, Pages 335-337

  Zhou, Tian Biao ^a   Jiang, Zong Pei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

MiR 21; Renal diseases; Signaling pathways; Transforming growth factor

Indexed keywords

MICRORNA 21; MICRORNA; MIRN21 MICRORNA, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; HUMAN; KIDNEY CARCINOMA; KIDNEY DISEASE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; FIBROSIS; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; MICRORNAS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907199605     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2014.896382     Document Type: Review

References (29)

1. Denby L, Ramdas V, McBride MW, et al. miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 2011;179:661-72.
2. Chung AC, Yu X, Lan HY. MicroRNA and nephropathy: Emerging concepts. Int J Nephrol Renovasc Dis 2013;6:169-79.
3. Patel V, Noureddine L. MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens 2012;21:410-16.
4. He Y, Huang C, Li J. miR-21 is a critical therapeutic target for renal fibrosis. Cell Biochem Biophys 2013. [Epub ahead of print].
5. Li YF, Jing Y, Hao J, et al. MicroRNA-21 in the pathogenesis of acute kidney injury. Protein Cell 2013;4:813-19.
6. Saikumar J, Hoffmann D, Kim TM, et al. Expression, circulation, and excretion profile of microRNA-21,-155, and-18a following acute kidney injury. Toxicol Sci 2012;129:256-67.
7. Du J, Cao X, Zou L, et al. MicroRNA-21 and risk of severe acute kidney injury and poor outcomes after adult cardiac surgery. PLoS One 2013;8:e63390.
8. Jia P, Teng J, Zou J, et al. miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice. Anesthesiology 2013;119:621-30.
9. Kaucsar T, Revesz C, Godo M, et al. Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury. Nucleic Acid Ther 2013;23:344-54.
10. Zhang Z, Peng H, Chen J, et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 2009;583:2009-14.
11. Fiorentino L, Cavalera M, Mavilio M, et al. Regulation of TIMP3 in diabetic nephropathy: A role for microRNAs. Acta Diabetol 2013; 50:965-9.
12. Dey N, Das F, Mariappan MM, et al. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem 2011;286: 25586-603.
13. Wang J, Gao Y, Zhang N, et al. Tongxinluo ameliorates renal structure and function by regulating miR-21-Induced epithelial-mesenchymal transition in diabetic nephropathy. Am J Physiol Renal Physiol 2013. [Epub ahead of print].
14. Zhong X, Chung AC, Chen HY, et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013;56:663-74.
15. Wang J, Gao Y, Ma M, et al. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys 2013;67:537-46.
16. Szeto CC, Ching-Ha KB, Ka-Bik L, et al. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Markers 2012;33:137-44.
17. Meng XM, Chung AC, Lan HY. Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) 2013;124:243-54.
18. Juan D, Alexe G, Antes T, et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010;75:835-41.
19. Zhang H, Guo Y, Shang C, et al. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. Urology 2012;80:1298-302.
20. Faragalla H, Youssef YM, Scorilas A, et al. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn 2012;14:385-92.
21. Zhang A, Liu Y, Shen Y, et al. miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma. Urology 2011;78: 474.e13-19.
22. Zaman MS, Shahryari V, Deng G, et al. Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One 2012;7:e31060.
23. Li S, Mariappan N, Megyesi J, et al. Proximal tubule PPARalpha attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction. Am J Physiol Renal Physiol 2013;305: F618-27.
24. Zhong X, Chung AC, Chen HY, et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011;22: 1668-81.
25. Chung AC, Dong Y, Yang W, et al. Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3-regulated microRNAs. Mol Ther 2013;21:388-98.
26. Zarjou A, Yang S, Abraham E, et al. Identification of a microRNA signature in renal fibrosis: Role of miR-21. Am J Physiol Renal Physiol 2011;301:F793-801.
27. Glowacki F, Savary G, Gnemmi V, et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One 2013; 8:e58014.
28. Bera A, Ghosh-Choudhury N, Dey N, et al. NFkappaB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell Signal 2013;25:2575-86.
29. Chau BN, Xin C, Hartner J, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 2012;4:121-18.